$Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir$

Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir

Cytomegalovirus (CMV) infection is widespread in the general population. In patients with severe and/or steroid-refractory ulcerative colitis (UC), local reactivation of CMV can be detected in actively inflamed colonic tissue in approximately 30% of cases. However, the role of CMV in patients with U...

Full description

Bibliographic Details
Main Authors:	Tiziana Larussa, Evelina Suraci, Immacolata Nazionale, Francesco Conforti, Maria Imeneo, Francesco Luzza
Format:	Article
Language:	English
Published:	MDPI AG 2012-11-01
Series:	Gastroenterology Insights
Subjects:	ulcerative colitis, cytomegalovirus, valganciclovir, ganciclovir
Online Access:	http://www.pagepress.org/journals/index.php/gi/article/view/3162

Similar Items

Hidrops fetal por infección congénita por citomegalovirus: tratamiento posneonatal prolongado con valganciclovir
by: Silvia Campos Arca, et al.
Published: (2012-01-01)

Cytomegalovirus colitis in a human immunodeficiency virus seropositive individual with moderately severe immunodeficiency
by: M.V.S. Subbalaxmi, et al.
Published: (2014-01-01)

Efficacy of Low Dose Valganciclovir Prophylaxis for Cytomegalovirus Infection in Kidney Transplantation
by: Ümit Özçelik, et al.
Published: (2020-01-01)

Cytomegalovirus Retinitis in a Patient with Large Cell Diffuse Non-Hodgkin’s Lymphoma
by: Ali Kal
Published: (2021-08-01)

Treatment of congenital cytomegalovirus infection
by: Gyu Hong Shim
Published: (2023-09-01)

Successful treatment of cytomegalovirus pneumonia in a child on maintenance chemotherapy for acute lymphoblastic leukemia without the use of intravenous immunoglobulin
by: Sidharth Totadri, MD, DM, et al.
Published: (2017-03-01)

Cytomegalovirus-associated esophageal ulcer in an immunocompetent infant: When should ganciclovir be administered?
by: Hyo-Jeong Jang, et al.
Published: (2012-12-01)

Letermovir for Cytomegalovirus Prophylaxis in Lung Transplant Patients with Valganciclovir-Induced Leukopenia
by: Arindam Singha, et al.
Published: (2021-04-01)

Role of oral valganciclovir in sick preterm with cytomegalovirus virus infection and ventilation dependence
by: Anumodan Gupta, et al.
Published: (2019-01-01)

Cytomegalovirus infection in the setting of occult ulcerative colitis: case report and review of the literature
by: Mustafa Dawood, et al.
Published: (2018-11-01)

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis
by: Siavash Vaziri, et al.
Published: (2014-01-01)

Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma
by: Giuseppe Stragliotto, et al.
Published: (2020-09-01)

Detection of antiviral drug resistance in patients with congenital cytomegalovirus infection using long-read sequencing: a retrospective observational study
by: Yuka Torii, et al.
Published: (2022-06-01)

Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report
by: Giovanni Carpani, et al.
Published: (2019-01-01)

Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
by: Moritz B. Immohr, et al.
Published: (2021-12-01)

Valganciclovir—Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship
by: Alicia Galar, et al.
Published: (2021-01-01)

Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial
by: Tomas Reischig, et al.
Published: (2018-11-01)

Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma
by: Mattia Russel Pantalone, et al.
Published: (2022-04-01)

Synchronous cytomegalovirus infection in a newly diagnosed ulcerative colitis patient
by: Jin Yu Chieng, et al.
Published: (2017-12-01)

Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir
by: Wenyu Yang, et al.
Published: (2023-06-01)

Cytomegalovirus Gastric Ulcer Complicated with Pyloric Obstruction in a Patient with Ulcerative Colitis
by: Sung Hwan Kang, et al.
Published: (2017-06-01)

Oral Administration of Valganciclovir Reduces Clinical Signs, Virus Shedding and Cell-Associated Viremia in Ponies Experimentally Infected with the Equid Herpesvirus-1 C<sub>2254</sub> Variant
by: Côme J. Thieulent, et al.
Published: (2022-05-01)

Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative Colitis
by: Jaeyoung Chun, et al.
Published: (2015-01-01)

Fifteen-Year Surveillance of LTR Receiving Pre-Emptive Therapy for CMV Infection: Prevention of CMV Disease and Incidence of CLAD
by: Davide Piloni, et al.
Published: (2022-11-01)

Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis
by: Diana D. Wong, et al.
Published: (2022-06-01)

Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation
by: LU Xuan, et al.
Published: (2020-09-01)

Bilateral cytomegalovirus retinitis in a healthy infant
by: Seyedeh Maryam Hosseini, et al.
Published: (2017-03-01)

Oral Valganciclovir Therapy in Infants Aged ≤2 Months with Congenital Cytomegalovirus Disease: A Multicenter, Single-Arm, Open-Label Clinical Trial in Japan
by: Ichiro Morioka, et al.
Published: (2022-06-01)

Cytomegalovirus Colitis with a Cobblestone Appearance
by: Kimitoshi Kubo, et al.
Published: (2020-05-01)

Assessment of relationship between active ulcerative colitis and cytomegalovirus infection among Iranian patients
by: Mojgan Mokhtari, et al.
Published: (2012-01-01)

Presumed cytomegalovirus retinitis in a non-immune compromised patient with breast carcinoma during treatment: A case report
by: Chia-Chen Kao, et al.
Published: (2021-09-01)

Complete elimination of cytomegalovirus without antiviral therapy after systemic mesenchymal stromal cell transplantation in a patient with ulcerative colitis (a clinical case)
by: O V Kniazev, et al.
Published: (2012-12-01)

Cytomegalovirus proctitis in non-human immunodeficiency virus infected patients: A case report and literature review
by: Kai-Yuan Liu, et al.
Published: (2022-02-01)

Distribution of cytomegalovirus genotypes among ulcerative colitis patients in Okinawa, Japan
by: Saifun Nahar, et al.
Published: (2018-01-01)

Diagnosis and Treatment of Ulcerative Colitis with Cytomegalovirus Infection: Importance of Controlling Mucosal Inflammation to Prevent Cytomegalovirus Reactivation
by: Hiroshi Nakase, et al.
Published: (2014-01-01)

Treating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: a retrospective analysis of routinely collected data
by: Jillian Murray, et al.
Published: (2020-11-01)

Risk Factors of Cytomegalovirus Reactivation in Ulcerative Colitis Patients: A Meta-Analysis
by: Yafei Qin, et al.
Published: (2021-10-01)

Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers
by: Cornelius Engelmann, et al.
Published: (2020-07-01)

IgA, albumin, and eosinopenia as early indicators of cytomegalovirus infection in patients with acute ulcerative colitis
by: Hong Yang, et al.
Published: (2020-09-01)

Lack of resistance-associated mutations in UL54 and UL97 genes of circulating Cytomegalovirus strains isolated in a medical center in Taiwan
by: Pei-Lan Shao, et al.
Published: (2012-08-01)